NEW TECHNOLOGY & SCIENCE NEWS

Vo Trong Nghia Architects once again adds greenery to its architecture with its most recent project, Chicland Hotel. The building is part-covered in plants and squeezes into a cramped and awkward plot near the beach in Vietnam.

Back in February, Vlad Kreimer of Soma Laboratory announced the creation of a Dvina prototype, the first electro-acoustic instrument from the Russian synth maker. Now the slightly-tweaked production model has been released.

After hitting the scene with an innovative expanding roof-top tent, iKamper reworked it, set Kickstarter on fire with a $2 million campaign, and became a brand name in the camping scene. Now it's reaching out to small car owners with a Mini version.

With the EyeQue VisionCheck, you can finally test your own eyes and order glasses from the comfort of your own home — without the extra doctor's bill. This handy device retails for $69, but you can order one today for $46.99.

Scientists in Korea believe they’ve found a way around the opaque nature of conventional solar cells, with a new technique that involves punching carefully placed holes right through them to make them transparent.

A comprehensive new study has tracked long-term ice loss in Greenland, and found that the Ice Sheet has lost 3.8 trillion tonnes of ice since 1992 – and the annual rate is rising faster than previously expected.

Blue Origin's New Shepard booster completed its 12th successful test flight on December 11, marking the first time a booster has made six consecutive missions. At 11:53 am CDT, the single-stage rocket lifted off for a 10 min 16 sec flight.

Italian electric motorcycle manufacturer Tacita is preparing to launch a new rally-focused bike in early January – and has just announced that it'll take the T-Race Rally out for a public debut at the world's greatest and most historic rally event.

A study is suggesting a neural circuit implicated in overeating may be more broadly linked to impulse control. The research hypothesizes behavioral disorders, from drug addiction to excessive gambling, could be treated by regulating this pathway.

Researchers are reporting positive results from an early trial exploring the safety profile of psilocybin doses in healthy adults. The trial also explored the potential of group dosing sessions as a way to speed up research and expand patient access.